Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)+ and FoxP3- T cells in complete DiGeorge anomaly

Clinical and Experimental Immunology

Volumn 173, Issue 1, 2013, Pages 140-149

  Chinn, I K ^a   Milner, J D ^b   Scheinberg, P ^b,c   Douek, D C ^b   Markert, M L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

DiGeorge; FoxP3; Repertoire; Thymus; Transplantation

Indexed keywords

CD3 ANTIGEN; GENOMIC DNA; MESSENGER RNA; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; AUTOIMMUNITY; BACTERIUM COLONY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DIGEORGE SYNDROME; DNA SEQUENCE; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHADENOPATHY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THYMUS TRANSPLANTATION; TISSUE GRAFT;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CLONE CELLS; DIGEORGE SYNDROME; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOPHENOTYPING; INFANT; LYMPHOPOIESIS; MALE; POSTOPERATIVE PERIOD; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 84878791766     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12088     Document Type: Article

References (32)

1. DiGeorge AM. Discussion of Cooper MD, Peterson RDA, Good RA. A new concept of cellular basis of immunity. J Pediatr 1965; 67:907-908.
2. Conley ME, Beckwith JB, Mancer JFK, Tenckhoff L. The spectrum of the DiGeorge syndrome. J Pediatr 1979; 94:883-890.
3. Müller W, Peter H, Wilken M etal. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 1988; 147:496-502.
4. Bastian J, Law S, Vogler L etal. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 1989; 115:391-396.
5. Markert ML, Hummell DS, Rosenblatt HM etal. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 1998; 132:15-21.
6. Markert ML, Alexieff MJ, Li J etal. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood 2004; 104:2574-2581.
7. Markert ML, Alexieff MJ, Li J etal. Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol 2004; 113:734-741.
8. Markert ML, Devlin BH, Alexieff MJ etal. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood 2007; 109:4539-4547.
9. Markert ML, Boeck A, Hale LP etal. Thymus transplantation in complete DiGeorge syndrome. N Engl J Med 1999; 341:1180-1189.
10. Markert ML, Sarzotti M, Ozaki DA etal. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood 2003; 102:1121-1130.
11. Rice HE, Skinner MA, Mahaffey SM etal. Thymic transplantation for complete DiGeorge syndrome: medical and surgical considerations. J Pediatr Surg 2004; 39:1607-1615.
12. Markert ML, Devlin BH, Chinn IK, McCarthy EA. Thymus transplantation in complete DiGeorge anomaly. Immunol Res 2009; 44:61-70.
13. Markert ML, Devlin BH, McCarthy EA. Thymus transplantation. Clin Immunol 2010; 135:236-246.
14. + regulatory T cells: more of the same or a division of labor? Immunity 2009; 30:626-635.
15. Bennett CL, Christie J, Ramsdell F etal. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-21.
16. Wildin RS, Ramsdell F, Peake J etal. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
17. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061.
18. + regulatory T cells. Int Immunol 2004; 16:1643-1656.
19. Milner JD, Ward JM, Keane-Myers A, Paul WE. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc Natl Acad Sci USA 2007; 104:576-581.
20. + T regulatory cells with limited TCR diversity in control of autoimmunity. J Immunol 2010; 184:56-66.
21. Haribhai D, Williams Jason B, Jia S etal. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 2011; 35:1-14.
22. + T-cell expansions that are distinctly modulated upon thymic transplantation. PLoS ONE 2012; 7:e37042.
23. - T cells. J Clin Invest 2003; 112:1437-1443.
24. + cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements. J Immunol Methods 2007; 321:107-120.
25. Volpe JM, Cowell LG, Kepler TB. SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations. Bioinformatics 2006; 22:438-444.
26. Brochet X, Lefranc M-P, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008; 36:W503-508.
27. +CD25 T cells. J Immunol 2007; 179:3412-3416.
28. + Treg cells. J Exp Med 2006; 203:1701-1711.
29. Seddiki N, Santner-Nanan B, Martinson J etal. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-1700.
30. + T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012; 36:262-275.
31. Allan SE, Crome SQ, Crellin NK etal. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19:345-354.
32. Shearer WT, Rosenblatt HM, Gelman RS etal. Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatric AIDS clinical trials group P1009 study. J Allergy Clin Immunol 2003; 112:973-980.